Bank Of America Corp Oncocyte Corp Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.2 - $0.35 $1,582 - $2,769	7,913 Added 30.1%	34,201 $7,000
Q1 2023 May 12, 2023	SELL	$0.2 - $0.49 $2,821 - $6,911	-14,106 Reduced 34.92%	26,288 $9,000
Q4 2022 Feb 10, 2023	SELL	$0.25 - $15.6 $5,702 - $355,820	-22,809 Reduced 36.09%	40,394 $12,000
Q3 2022 Nov 14, 2022	SELL	$0.76 - $15.98 $41,545 - $873,546	-54,665 Reduced 46.38%	63,203 $46,000
Q2 2022 Aug 12, 2022	BUY	$0.86 - $1.53 $82,029 - $145,935	95,383 Added 424.21%	117,868 $106,000
Q1 2022 May 16, 2022	SELL	$1.15 - $2.25 $12,638 - $24,727	-10,990 Reduced 32.83%	22,485 $33,000
Q4 2021 Feb 08, 2022	BUY	$2.04 - $3.59 $11,438 - $20,129	5,607 Added 20.12%	33,475 $73,000
Q3 2021 Nov 15, 2021	BUY	$3.53 - $5.89 $5,287 - $8,823	1,498 Added 5.68%	27,868 $99,000
Q2 2021 Sep 13, 2021	BUY	$3.77 - $6.0 $99,414 - $158,220	26,370 New	26,370 $151,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.